ELS-tíðindi - janúar 2002 - Einkaleyfastofan

1/02
(21) 6136
(22) 30.10.2001
(41) 30.10.2001
(51) C07C 233/36; C07D 295/13; C07D
215/46; A61K 31/167; A61K 31/445;
A61K 31/47; A61P 25/28
(54) Arómatísk amíð.
(71) Warner-Lambert Company, 201
Tabor Road, Morris Plains, New
Jersey 07950, Bandaríkjunum.
(72) Justin Stephen Bryans, Balsham;
John Colm O´Toole, Linton,
Cambridge; David Christopher Horwell,
Foxton, Cambridge; Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 10.5.99, US, 60/133,359
(85) 30.10.2001
(86) 10.5.2000, PCT/GB00/01788
(21) 6137
(22) 30.10.2001
(41) 30.10.2001
(51) A61K 31/343; A61P 25/00; A61P 25/22
(54) Meðhöndlun á hugsýkistruflunum.
(71) H. Lundbeck A/S., 9, Ottiliavej, DK-
2500 Valby-Copenhagen, Danmörku.
(72) Connie Sanchez, Glostrup; Sandra
Hogg, Frederiksberg C; Danmörku.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 8.7.99, DK, PA 1999 00991
(85) 30.10.2001
(86) 7.7.2000, PCT/DK00/00377
(21) 6138
(22) 30.10.2001
(41) 30.10.2001
(51) C07D 215/54; A61K 31/47; A61P
43/00; C07D 405/12; C07D 401/12;
C07D 417/12; C07D 413/12; C07D
409/12
(54) Kínólín afleiður sem latar fyrir MEK
ensím.
(71) AstraZeneca AB, S-151 85 Södertälje,
Svíþjóð.
(72) Francis Thomas Boyle; Keith
Hopkinson Gibson; Jeffrey Philip
Poyser; Paul Turner; Cheshire,
Bretlandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 8.5.99, GB, 9910577.7
(85) 30.10.2001
(86) 3.5.2000, PCT/GB00/01697
(21) 6145
(22) 6.11.2001
(41) 6.11.2001
(51) F17C 5/06
(54) Áfyllingaraðferð og -kerfi fyrir
vetniseldsneyti.
(71) Stuart Energy Systems Corporation,
122 The West Mall, Toranto, Ontario,
M9C 1B9, Kanada.
(72) Matthew J. Fairlie; William J. Stewart;
Andrew T.B. Stuart; Steven J.
Thorpe; Charlie Dong; Toronto,
Ontario, Kanada.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 12.5.99, CA, 2,271,450
(85) 6.11.2001
(86) 28.4.2000, PCT/CA00/00487
ELS tíðindi 67
(21) 6146
(22) 6.11.2001
(41) 6.11.2001
(51) C01B 3/00
(54) Orkudreifingarnet.
(71) Stuart Energy Systems Corporation,
122 The West Mall, Toranto, Ontario,
M9C 1B9, Kanada.
(72) Matthew J. Fairlie; William J. Stewart;
Andrew T.B. Stuart; Steven J.
Thorpe; Charlie Dong; Toronto,
Ontario, Kanada.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 12.5.99, CA, 2,271,448
(85) 6.11.2001
(86) 28.4.2000, PCT/CA00/00488
(21) 6148
(22) 7.11.2001
(41) 7.11.2001
(51) A01K 61/00
(54) Innri ventill fyrir fiskibúr.
(71) Helgeland Holding AS, c/o
Helgeland Plast AS, N-8607, Mo I
Rana, Noregi.
(72) Dag Kolberg, Båsmoen, Noregi.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Skeifunni 7, 108 Reykjavík.
(30) 31.5.99, NO, 1999 2614
(85) 7.11.2001
(86) 30.5.2000, PCT/NO00/00184
(21) 6149
(22) 7.11.2001
(41) 7.11.2001
(51) F25C 5/18; F25C 5/00
(54) Búnaður til geymslu á ís sem ætlaður
er til að afhlaða ísinn.
(71) Odd-Harry Mikkelsen; Thor Nerhus,
Utsikten 3, N-4026 Stavanger; N-5637
Ølve, Noregi.
(72) Odd Harry Mikkelsen, Stavanger;
Thor Nerhus, Ølve; Noregi.
(74) PATICE, Ólafur Ragnarsson, hrl.,
Skeifunni 7, 108 Reykjavík.
(30) 7.5.99, NO, 19992220
(85) 7.11.2001
(86) 11.4.2000, PCT/NO00/00115
(21) 6150
(22) 8.11.2001
(41) 8.11.2001
(51) A61K 35/74; A23L 1/03; A61P 13/04;
A61P 13/12; A61P 15/02
(54) Næringar- eða lyfjasamsetningar til
nota við fyrirbyggingu eða
meðhöndlun á ofurkalsíum oxalat
myndun.
(71) Mendes S.R.L., Via Nuoro, 12, I-
00040 Ardea, Ítalíu.
(72) Claudio De Simone, Ardea, Ítalíu.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 28.5.99, IT, RM99A000338
(85) 8.11.2001
(86) 24.5.2000, PCT/IT00/00213
(21) 6151
(22) 8.11.2001
(41) 8.11.2001
(51) A61K 31/44; A61K 9/50
(54) Örkorn óleysanleg í magavökva,
aðferð til að afla þeirra og
lyfjaefnablöndur.
(71) Laboratoires des Produits
Ethiques Ethypharm, 21, rue Saint-
Mathieu, F-78550 Houdan,
Frakklandi.
(72) Bruno Criere, Gravigny; Pascal
Suplie, Montaure; Pascal Oury, Le
Chesnay; Frakklandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 21.5.99, FR, 99/06,479
(85) 8.11.2001
(86) 19.5.2000, PCT/FR00/01367
(21) 6154
(22) 9.11.2001
(41) 9.11.2001
(51) A61K 39/395; A61K 38/17; A61K 39/39;
A61K 39/00; G01N 33/68; A61K 48/00;
A61P 25/28
(54) Efni til öftrunar og meðferðar mýlildis.
(71) Neuralab, 102 St. James Court,
Flatts, Smiths FL04, Bermudaeyjum.
(72) Dale B. Schenk, Burlingame;
Frederique Bard, Pacifica; Nicki J.
Vasquez, San Francisco; Ted
Yednock, Forest Knolls; California,
Bandaríkjunum.
(74) A&P Árnason ehf., Efstaleiti 5, 103
Reykjavík.
(30) 28.5.99, US, 09/322,289
(85) 9.11.2001
(86) 26.5.2000, PCT/US00/14810
(21) 6157
(22) 13.11.2001
(41) 13.11.2001
(51) A61K 31/4375; A61K 31/4402; A61K
31/4427; A61K 31/4985; A61K 31/505;
A61K 31/500; A61K 31/5365; A61K
31/55; A61P 19/10; C07D 213/02;
C07D 221/00; C07D 223/14; C07D
239/24; C07D 241/36; C07D 265/28;
C07D 471/02
(54) Alfa V integrín viðtaka mótlyf.
(71) Merck & Co., Inc., 126 East Lincoln
Avenue, Rahway, New Jersey
07065-0907, Bandaríkjunum.
(72) Paul J. Coleman; Mark E. Duggan;
Wasyl Halczenko; George D.
Hartman; John H. Hutchinson;
Robert S. Meissner; Michael A.
Patane; James J. Perkins; Jiabing
Wang; Michael J. Breslin; Rahway,
New Jersey, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 2.6.99, US, 60/137,101
31.1.2000, US, 60/179,216
(85) 13.11.2001
(86) 30.5.2000, PCT/US00/14901